What are study drugs?
Study drugs are prescription medications that are typically used to treat attention deficit hyperactivity disorder (ADHD) or narcolepsy but are sometimes misused by students to enhance concentration, focus, and productivity.
Common study drugs include:
- Ritalin (methylphenidate): Another stimulant that helps improve attention and control impulses. Currently the most commonly prescribed ADHD drug in the UK.
- Adderall (amphetamine/dextroamphetamine) not licensed for use in the UK and is not commonly prescribed in the UK. A popular stimulant prescribed in USA for ADHD. It increases focus and alertness. Adderall is a Class B controlled substance in the UK and heavily regulated worldwide, importing or possessing it without a prescription is illegal in many countries.
Why are they so popular?
- Academic pressure: Students feel intense pressure to perform well, leading them to seek a competitive edge.
- Perception of safety: Since these are prescription medications, they're perceived as safer than illicit drugs.
- Increased availability: They are more accessible due to the rising number of ADHD diagnoses and prescriptions.
- Success stories: Anecdotes from peers who claim improved focus and productivity encourage others to try them.
What are the potential problems associated with the widespread use of ADHD drugs
There is a genuine concern that the widespread use and misuse of study drugs could contribute to a generation with increased dependency on stimulants. Here’s why:
1. Potential for addiction:
- Chemical dependency: Medications like Adderall and Ritalin are stimulants that affect dopamine levels, creating a sense of reward and pleasure, which can lead to dependency and addiction.
- Tolerance and withdrawal: With regular misuse, users can develop a tolerance, needing higher doses to achieve the same effect, and may experience withdrawal symptoms when they stop.
2. Cultural normalisation:
- Pressure to perform: In a high-pressure, competitive academic environment, using cognitive enhancers is becoming normalised, leading students to believe they “need” drugs to succeed.
- Long-term habits: Starting stimulant use in school or university could establish long-term habits, potentially leading to dependency in the workplace for productivity.
3. Gateway to other substance abuse:
- Some studies suggest that misuse of prescription stimulants can increase the risk of experimenting with other substances, including illegal drugs.
4. Mental health implications:
- Anxiety and depression: Stimulant misuse can exacerbate mental health issues such as anxiety and depression, potentially leading to self-medication with other substances.
- Identity and self-worth: If students feel they can only succeed with study drugs, it can impact their self-esteem and increase psychological dependency.
Why are so many students being diagnosed with ADHD?
- Increased awareness and screening: Greater awareness among parents, teachers, and healthcare providers has led to more diagnoses.
- Broadening diagnostic criteria: The definition of ADHD has expanded, encompassing a wider range of behaviours.
- Educational environment: Demands for prolonged focus and productivity may highlight attention difficulties.
- Overdiagnosis concerns: Some experts worry that normal childhood behaviours are being pathologised, leading to overdiagnosis.
- Booming ADHD industry: This may also be fuelling the increase in diagnosis. Private experts diagnosing ADHD have turned it into a booming industry, fuelled by growing awareness and the desire for quick solutions to attention and productivity issues. With increasing academic and workplace pressures, more people are seeking assessments, leading to a surge in private clinics offering fast-track diagnoses. Unlike NHS clinics, which often have long waiting lists and stricter diagnostic criteria, private providers can offer quicker appointments and flexible evaluations. This has raised concerns about over diagnosis and the commercialisation of mental health, as some clinics may prioritise profit over accurate assessments, leading to unnecessary prescriptions of stimulant medications.
Which are the most commonly prescribed ADHD drugs in UK in 2025
As of 2025, the most commonly prescribed medications for Attention Deficit Hyperactivity Disorder (ADHD) in the UK are:
- Methylphenidate: This stimulant medication accounts for approximately 63% of ADHD prescriptions. source theguardian.com
- Lisdexamfetamine: Another stimulant, representing about 19% of prescriptions. source theguardian.com
These medications are favoured by doctors due to their efficacy in managing ADHD symptoms.
However, it's important to note that the UK has been experiencing significant shortages of ADHD medications, including methylphenidate and lisdexamfetamine, since late 2023. These shortages have led to challenges and stress for patients in obtaining their prescribed treatments. source nelft.nhs.uk
Additionally, there has been a notable increase in ADHD diagnoses and medication prescriptions, with nearly 278,000 patients in England receiving ADHD medications on prescription as of early 2025. This surge has raised concerns about potential overdiagnosis and the strain on medication supplies. Source thetimes.co.uk
Given these recent developments, healthcare providers and patients are encouraged to maintain open communication to manage treatment plans effectively during this period of medication shortages and increased demand.
Should we be worried?
Yes undoubtedly this is a concern for public health in the UK as well as for education. We may soon see a situation in the UK where where almost every child in the class at school or university has a diagnosis of ADHD, is on controlled prescription medications and getting extra time in exams.
- Health risks: Misuse of study drugs can cause side effects such as anxiety, insomnia, heart problems, and addiction.
- Ethical concerns: Using cognitive enhancers for academic gain raises ethical questions about fairness.
- Long-term effects: There’s limited research on the long-term impact of stimulant misuse on the developing brain.
- Mental health: Increased pressure to perform and reliance on medication could contribute to mental health issues.
- Physical and psychological dependence-study drugs are addictive, and students may end up feeling unable to cope without them.
The rise in ADHD diagnoses and study drug use is complex, involving societal, educational, and medical factors. While increased awareness and treatment are positive, the potential for over diagnosis and misuse is very concerning.
What can parents do?
- Seek a thorough evaluation: If you suspect your child has ADHD, choose a reputable healthcare provider who conducts comprehensive assessments, including behavioural observations, interviews with parents and teachers, and standardised tests. Avoid clinics promising quick diagnoses.
- Get a second opinion: If diagnosed privately, consider a second opinion from a trusted healthcare NHS professional, such as a paediatrician or child psychologist, to confirm the diagnosis. Private healthcare has a vested interest in over diagnosing.
- Educate yourself: Learn about ADHD symptoms, treatments, and behavioural strategies to make informed decisions. This reduces the risk of misdiagnosis and unnecessary medication.
- Promote healthy habits: Encourage regular exercise, a balanced diet, and adequate sleep, which can greatly improve focus and behaviour.
- Consider non-medication approaches: Behavioural therapy, organisational coaching, and educational support can be effective alternatives or complements to medication.
- Monitor and communicate: If your child is prescribed medication, closely monitor their response and maintain open communication with the healthcare provider to adjust treatment as needed.
- Advocate at school: Work with teachers to implement classroom strategies that support your child’s learning style, such as seating arrangements and personalised learning plans.
- Support emotional wellbeing: Help your child build self-esteem and resilience by emphasising their strengths and offering positive reinforcement.
By staying informed, seeking balanced evaluations, and considering a range of interventions, parents can ensure their child receives the right support without unnecessary reliance on medication.
What are the implication for workplace drug testing as these young adults enter the workplace?
The increasing use of ADHD medications and 'study drugs' has significant implications for workplace drug testing. As more young adults are prescribed these controlled stimulants, employers must navigate the balance between medical necessity and workplace policies on controlled substances.
Many standard workplace drug tests in the UK can detect some of these stimulants, potentially leading to complications for employees who rely on them. Some stimulant drugs can be detected in standard drug tests under the amphetamine panels. Interestingly not all study drugs will test positive on an amphetamine drug test—it depends on the specific medication and the type of drug test used. Methylphenidate (Ritalin) should not show up as an amphetamine on a drug test, however due to cross reactivity it sometimes does give a positive. Ritalin may be detected in drug tests specifically looking for stimulants, but not on all standard amphetamine screens.
This raises ethical and legal concerns, as employers must ensure they do not discriminate against individuals with legitimate prescriptions while maintaining fair and safe working environments. Additionally, with some individuals misusing these drugs for productivity enhancement, UK companies may need to adapt their drug policies to address both prescription use and potential abuse of stimulants in the workplace
Is it inevitable that we will see widespread use and misuse of these drugs in education and at work?
Not necessarily. The key lies in:
- Education and awareness: Teaching students about the risks and promoting healthy study habits.
- Proper diagnosis and treatment: Ensuring ADHD is accurately diagnosed and managed without overprescribing stimulants.
- Mental health support: Providing resources to manage academic pressure and mental health without turning to drugs.
The risk is real, but it's not inevitable if addressed with balanced education, responsible medical practices, and cultural shifts in how we view productivity and success